Search
01/02/2024
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting
Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Giménez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mir, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. DIABETES CARE. 2024; 47(2)DOI:10.2337/dc23-1355. PMID:37948469. IF:16.600(Q1/1D).
15/01/2024
The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review
Sloan, L, Cheng, AYY, Escalada, J, Haluzík, M, Mauricio, D. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review. DIABETES OBESITY & METABOLISM. 2024; 26(4)DOI:10.1111/dom.15425. PMID:38225217. IF:5.700(Q1/2D).
01/01/2024
Type 2 Diabetes and HDL dysfunction: a key contributor to Glycemic Control.
Rotllan N, Julve J, Escolà-Gil JC. Type 2 Diabetes and HDL dysfunction: a key contributor to Glycemic Control.. CURRENT MEDICINAL CHEMISTRY. 2024; 31(3)DOI:10.2174/0929867330666230201124125. PMID:36722477. IF:3.500(Q2/4D).
01/01/2024
The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
Chico A., Moreno-Fernández J., Fernández-García D., Solá E.. The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization. Diabetes Therapy. 2024; 15(1)DOI:10.1007/s13300-023-01486-2. PMID:37857988. IF:2.600(Q3/6D).
01/01/2024
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
Rodríguez-Agudo, R, González-Recio, I, Serrano-Maciá, M, Bravo, M, Petrov, P, Blaya, D, Herranz, JM, Mercado-Gómez, M, Rejano-Gordillo, CM, Lachiondo-Ortega, S, Gil-Pitarch, C, Azkargorta, M, Van Liempd, SM, Martinez-Cruz, LA, Simao, AL, Elortza, F, Martín, C, Nevzorova, YA, Cubero, FJ, Delgado, TC, Argemi, J, Bataller, R, Schoonjans, K, Banales, JM, Castro, RE, Sancho-Bru, P, Avila, MA, Julve, J, Jover, R, Mabe, J, Simon, J, Goikoetxea-Usandizaga, N, Martínez-Chantar, ML. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1. Jhep Reports. 2024; 6(1)DOI:10.1016/j.jhepr.2023.100918. PMID:38192540. IF:7.500(Q1/2D).
01/01/2024
Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019
Soldevila B., Alarcón L., Vlacho B., Real J., Hernández M., Cos X., Franch-Nadal J., Mauricio D.. Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019. Primary Care Diabetes. 2024; 18(2)DOI:10.1016/j.pcd.2023.12.007. PMID:38228411. IF:2.300(Q2/5D).